Monocytosis is a rare blood disorder that affects a person’s white blood cells. It is a condition in which there is an abnormal increase in the number of monocytes, a type of white blood cell, in the bloodstream. Monocytosis can be caused by a variety of underlying conditions, including certain types of infections, medications, and autoimmune diseases. While it is not a life-threatening condition, it can be a sign of an underlying problem that needs to be addressed. In this article, we will provide an overview of monocytosis and discuss the various causes, symptoms, and treatments available.
Monocytosis is a rare blood disorder characterized by an abnormal increase in the number of monocytes in the bloodstream. Monocytes are a type of white blood cell that helps fight infection and are produced in the bone marrow. Normally, monocytes make up only a small percentage of the total white blood cell count, usually between 0.5-2.0%. However, in monocytosis, the number of monocytes can be up to 10% or higher.
Monocytosis can be caused by a variety of underlying conditions, including infections, medications, and autoimmune diseases. Some of the most common causes of monocytosis include: • Infections: Certain types of infections, such as bacterial, viral, and fungal, can cause an increase in the number of monocytes in the bloodstream. • Medications: Certain medications, such as antibiotics, can cause an increase in the number of monocytes in the bloodstream. • Autoimmune diseases: Autoimmune diseases, such as lupus and rheumatoid arthritis, can cause an increase in the number of monocytes in the bloodstream. • Cancer: Some types of cancer, such as leukemia and lymphoma, can cause an increase in the number of monocytes in the bloodstream. • Other conditions: Other conditions, such as kidney or liver disease, can cause an increase in the number of monocytes in the bloodstream.
Monocytosis is usually asymptomatic, meaning that it does not cause any noticeable symptoms. However, some people with monocytosis may experience the following symptoms: • Fatigue • Fever • Chills • Night sweats • Weight loss • Shortness of breath • Joint pain • Abdominal pain
Diagnosing monocytosis typically involves a physical examination and a blood test. During the physical examination, your doctor will look for signs of infection or other conditions that could be causing the monocytosis. The blood test will measure the number of monocytes in the bloodstream. If the number is higher than normal, it is an indication of monocytosis.
Treatment for monocytosis typically depends on the underlying cause. If an infection is causing the monocytosis, your doctor may prescribe antibiotics to treat the infection. If a medication is causing the monocytosis, your doctor may reduce the dosage or switch to a different medication. If an autoimmune disease is causing the monocytosis, your doctor may prescribe immunosuppressant medications to reduce inflammation and suppress the immune system.
Monocytosis is a rare blood disorder that is characterized by an abnormal increase in the number of monocytes in the bloodstream. It can be caused by a variety of underlying conditions, including infections, medications, and autoimmune diseases. While it is not a life-threatening condition, it can be a sign of an underlying problem that needs to be addressed. If you have any of the symptoms associated with monocytosis, it is important to see your doctor for a proper diagnosis and treatment.
1.
PSA Often Unchanged With Enzalutamide Progression
2.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
3.
What Do Patients Want Doctors to Know About Breast Cancer Recurrence?
4.
GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer
5.
NP-Led Outreach Ups Cancer Screening in Rural Women Veterans
1.
Modern Techniques in Hematology Across Clinical Settings
2.
Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment
3.
Progressive Techniques in Oncology in Daily Practice
4.
Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells
5.
Segmental vs. Non-Segmental Vitiligo: What’s the Difference?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Emerging Concepts in Hematology
2.
Navigating the Complexities of Ph Negative ALL - Part V
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
Navigating the Complexities of Ph Negative ALL - Part III
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation